Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study

Biochemistry, Genetics and Molecular Biology

• Immunity 100%
• Chemokine 100%
• Sample 75%
• Contrast 50%
• Macrophage 25%
• Cross Sectional Study 25%
• Mediator 25%
• down Regulation 25%
• Blood Level 25%
• Proinflammatory Cytokine 25%
• Cell Adhesion Proteins 25%
• Cytokine 25%
• T Cell 25%
• Interleukin 6 25%
• Synapsin I 25%
• Interleukin 15 25%
• Interleukin 8 25%
• Interleukin 10 25%
• Interferon Gamma 25%
• Monokine 25%
• Interleukin 1 Receptor Antagonist 25%
• Monocyte 25%

Medicine and Dentistry

• Patient 100%
• Immunity 100%
• Acute Pancreatitis 100%
• Chronic Pancreatitis 100%
• Chemokine 14%
• Serums 14%
• Inflammatory Mediator 7%
• Cytokine 7%
• Assay 7%
• Anti-Inflammatory Drug 7%
• Cross Sectional Study 7%
• down Regulation 7%
• Monocyte Chemotactic Protein 1 7%
• Interleukin 1 Receptor Blocking Agent 7%
• Inflammation 7%
• CXCL9 Chemokine 7%
• Interleukin 8 7%
• Macrophage Derived Chemokine 7%
• Inflammatory Cytokine 7%
• Interleukin 6 7%
• Interleukin 15 7%
• Interleukin 10 7%
• Evaluation 7%
• Cell Adhesion Proteins 7%

Immunology and Microbiology

• Immunity 100%
• Acute Pancreatitis 100%
• Pancreatitis 100%
• Sample 27%
• Contrast 18%
• Chemokine 18%
• Systemic Inflammation 9%
• Mediator 9%
• Proinflammatory Cytokine 9%
• Blood Level 9%
• down Regulation 9%
• Interleukin 10 9%
• Monocyte Chemotactic Protein 1 9%
• Interleukin 1 Receptor Antagonist 9%
• Interleukin 6 9%
• CXCL9 Chemokine 9%
• Cell Adhesion Proteins 9%
• Macrophage Derived Chemokine 9%
• Cutaneous T Cell Attracting Chemokine 9%
• Cytokine 9%
• Interleukin 15 9%
• Interleukin 8 9%